Phase II B Trial – Talk Bio

Actionable Insights Powered by AI

Cartesian Therapeutics Announces Positive Phase 2b Results for Descartes-08 in Myasthenia Gravis Treatment

10 months ago talkbio0Tagged Autoimmune, Autoimmune Diseases, Autologous Anti-BCMA-CAR-mRNA-transfected CD8+ T-lymphocytes, CAR-T, Cartesian, Myasthenia Gravis, Phase II B Trial

Cartesian Therapeutics, Descartes-08, Myasthenia Gravis, Phase 2b Trial, CAR-T Therapy, Autoimmune Disorder

Jazz Pharmaceuticals’ Essential Tremor Drug Candidate Fails to Meet Primary Endpoint in Phase IIb Trial

10 months ago talkbio0Tagged calcium channel modulator, Essential Tremor, Jazz, Phase II B Trial, Primary Endpoint

Jazz Pharmaceuticals, suvecaltamide, essential tremor, phase IIb trial, primary endpoint, calcium channel modulator